Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1070 ‘Decoy-resistant’ IL-18 in combination with CTLA-4 blockade enhances anti-tumor efficacy in preclinical models of renal cell carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
